Drug Topics November 13, 2024
Killian Meara

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

The National Average Drug Acquisition Cost (NADAC) is a benchmark that provides drug prices to the pharmaceutical supply chain. The prices, which are determined by averaging prices from retail community pharmacies across the United States, are gathered from the monthly Retail Price Survey conducted by the Centers for Medicare and Medicaid Services (CMS). NADAC aims to provide more accurate drug prices for states who use it as a reference price when setting their reimbursement methodology.

At the National Community Pharmacists Association (NCPA) 2024 Annual Convention and Expo, held October 26 to 29 in Columbus, Ohio, Drug Topics sat down with AJ Loiacono, co-founder and CEO of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Interview / Q&A, Pharma, Pharma / Biotech, Supply Chain, Technology, Trends
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
The financial burden of drug shortages: 7 study takeaways
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
AI In Healthcare: A New Era Of Personalized Patient Care

Share This Article